Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 36.5437.63-0.150.25-0.25

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 36.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202536.54
Mar202437.63
Mar2023-0.15
Mar20220.25
Mar2021-0.25

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 36.54
-2.90
Mar2024 37.63
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹88,648.8 Cr -2.8% -3.3% -15.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,581.0 Cr -1.8% 4.1% -1.6% Stock Analytics
DIVIS LABORATORIES ₹167,051.0 Cr -2.8% -3.7% 2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,367.0 Cr -0.2% -0.9% 12.9% Stock Analytics
CIPLA ₹120,289.0 Cr -2.1% -1.7% 0.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,421.0 Cr -2% 3.3% -0.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.8%

-3.3%

-15.7%

SENSEX

-0.8%

1%

3.2%


You may also like the below Video Courses